Epigenomics AG Stock Deutsche Boerse AG
Stocks
ECX
DE000A11QW50
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Deutsche Boerse AG
05/02/2024
|
5-day change | 1st Jan Change | ||
| 1.785 EUR | -1.92% |
|
+9.51% | -4.03% |
| 04:21pm | Epigenomics AG Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-02 | Epigenomics AG Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 789K 917K 741K 678K 1.26M 86.72M 1.27M 8.76M 3.41M 44.32M 3.44M 3.37M 143M | P/E 2024 |
-0.29x | P/E 2025 | -2.51x |
|---|---|---|---|---|---|
| Enterprise Value | 11.76M 13.66M 11.03M 10.09M 18.84M 1.29B 18.99M 131M 50.82M 660M 51.31M 50.19M 2.13B | EV / Sales 2024 |
-
| EV / Sales 2025 | 490x |
| Free-Float |
70.75% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.92% |
| Manager | Title | Age | Since |
|---|---|---|---|
Frederic Hilke
IRC | Investor Relations Contact | - | - |
| Corporate Officer/Principal | 55 | 01/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Helge Lubenow
CHM | Chairman | 58 | 01/03/2023 |
Alexander Link
BRD | Director/Board Member | 55 | 01/06/2020 |
Jochen Hummel
BRD | Director/Board Member | 56 | 05/02/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.92% | +9.51% | - | - | 915K | |
| -0.55% | -7.60% | +90.12% | +267.92% | 3.94B | |
| -0.52% | +4.36% | +290.05% | +42.72% | 3.9B | |
| -0.74% | -1.62% | +45.38% | +70.03% | 3.61B | |
| -0.63% | -6.42% | +284.92% | +436.11% | 2.57B | |
| -0.85% | -8.00% | -27.87% | -30.30% | 2.16B | |
| +0.20% | -12.13% | +211.65% | -27.11% | 1.1B | |
| -1.71% | -2.02% | +23.24% | +42.76% | 1.08B | |
| -1.93% | -11.52% | +14.96% | +58.95% | 625M | |
| -1.26% | -4.10% | -34.04% | -4.75% | 531M | |
| Average | -0.99% | -5.29% | +99.82% | +95.15% | 2.17B | |
| Weighted average by Cap. | -0.71% | -2.51% | +131.80% | +132.18% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 24K 27.89K 22.52K 20.61K 38.46K 2.64M 38.76K 266K 104K 1.35M 105K 102K 4.34M |
| Net income | -3.35M -3.9M -3.15M -2.88M -5.37M -368M -5.41M -37.21M -14.49M -188M -14.63M -14.31M -606M | -314K -365K -295K -270K -503K -34.5M -507K -3.49M -1.36M -17.63M -1.37M -1.34M -56.78M |
| Net Debt | 10.46M 12.15M 9.81M 8.98M 16.75M 1.15B 16.89M 116M 45.2M 587M 45.63M 44.64M 1.89B | 10.97M 12.75M 10.29M 9.42M 17.57M 1.2B 17.71M 122M 47.41M 616M 47.87M 46.82M 1.98B |
Employees
-
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ECX Stock
- ECX Stock
Select your edition
All financial news and data tailored to specific country editions
